Embed Code

Social Share

GW Pharmaceuticals, a trailblazer in the realm of cannabinoid-based medicine, has been instrumental in transforming the landscape of cannabis therapeutics. Established in 1998 by Dr. Geoffrey Guy and Dr. Brian Whittle, the company has dedicated itself to exploring the medicinal benefits of cannabis, particularly focusing on cannabinoids. The name “GW Pharmaceuticals” is derived from the initials of its founders, reflecting their commitment to advancing cannabis science. The company’s flagship product, Epidiolex, received FDA approval in 2018, marking a historic moment as the first cannabis-derived drug sanctioned for medical use in the United States. This milestone not only underscored the therapeutic potential of cannabis but also paved the way for further research and acceptance of cannabinoid-based treatments. As the cannabis industry continues to expand, GW Pharmaceuticals stands at the cutting edge, leading the charge in developing innovative solutions that harness the power of cannabis for health and wellness. For further reading, visit [GW Pharmaceuticals on Wikipedia](https://en.wikipedia.org/wiki/GW_Pharmaceuticals).

Edit Wiki Term

GW Pharmaceuticals (Wikipedia)

GW Pharmaceuticals Limited is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals.

GW Pharmaceuticals Limited
Formerly
  • GW Pharmaceuticals Group PLC (2001–2001)
  • GW Pharmaceuticals PLC (2001–2021)
Company typeSubsidiary
Nasdaq: GWPH
IndustryPharmaceutical industry
Founded1998; 28 years ago (1998)
Founder
  • Geoffrey Guy
  • Brian Whittle
HeadquartersCambridge,
United Kingdom
Key people
Justin Gover (CEO)
Products
RevenueIncrease $527 million (2020)
Decrease -$58 million (2020)
Total assetsIncrease $939 million (2020)
Total equityIncrease $741 million (2020)
Number of employees
1,161 (2020)
ParentJazz Pharmaceuticals
Websitegwpharm.co.uk Edit this at Wikidata
Footnotes / references
GW Pharma, GW, GW Pharma Ltd, GW Research, GW Biopharma
Do NOT Grow Another Plant Until You've Enrolled Into This! 💯
Cannabis Horticulture
A Carefully Curated Cultivation "Crash Course" On Everything You Need To Crank Out High-Yielding, "Cannabis-Cup Winner" Flowers That'll Generate HUGE Crops All-Year Long
Crafting Cannabis-Infused Edibles Takes MORE Than Ingredients... 🍽️
Edible Cannabis Products (100% FREE Training)
Enthusiasts Face Challenges Navigating An Ever-Expanding Array Of Cannabis Products & Delivery Methods From "Raw Flower" Smoothies To Infused-Edibles, Cannabinoid-Based Drinks + MORE.